nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Retinoids—Bexarotene—hematologic cancer	0.263	0.569	CiPCiCtD
Adapalene—Retinoids—Alitretinoin—hematologic cancer	0.199	0.431	CiPCiCtD
Adapalene—RARA—hematologic cancer	0.17	1	CbGaD
Adapalene—RXRG—Bexarotene—hematologic cancer	0.0453	0.168	CbGbCtD
Adapalene—RXRA—Bexarotene—hematologic cancer	0.04	0.149	CbGbCtD
Adapalene—RXRB—Bexarotene—hematologic cancer	0.04	0.149	CbGbCtD
Adapalene—RARG—Alitretinoin—hematologic cancer	0.026	0.0966	CbGbCtD
Adapalene—RXRG—Alitretinoin—hematologic cancer	0.026	0.0966	CbGbCtD
Adapalene—RARA—Alitretinoin—hematologic cancer	0.023	0.0854	CbGbCtD
Adapalene—RARB—Alitretinoin—hematologic cancer	0.023	0.0854	CbGbCtD
Adapalene—RXRA—Alitretinoin—hematologic cancer	0.023	0.0854	CbGbCtD
Adapalene—RXRB—Alitretinoin—hematologic cancer	0.023	0.0854	CbGbCtD
Adapalene—RARG—hematopoietic system—hematologic cancer	0.000781	0.0941	CbGeAlD
Adapalene—RARA—hematopoietic system—hematologic cancer	0.000735	0.0884	CbGeAlD
Adapalene—RARA—gonad—hematologic cancer	0.000558	0.0672	CbGeAlD
Adapalene—RARB—lung—hematologic cancer	0.000556	0.067	CbGeAlD
Adapalene—RARG—blood—hematologic cancer	0.000518	0.0623	CbGeAlD
Adapalene—RXRG—testis—hematologic cancer	0.000513	0.0618	CbGeAlD
Adapalene—RXRB—lung—hematologic cancer	0.000511	0.0615	CbGeAlD
Adapalene—RARA—blood—hematologic cancer	0.000487	0.0586	CbGeAlD
Adapalene—RXRB—testis—hematologic cancer	0.000482	0.0581	CbGeAlD
Adapalene—RARA—bone marrow—hematologic cancer	0.000471	0.0567	CbGeAlD
Adapalene—RARG—lung—hematologic cancer	0.000454	0.0546	CbGeAlD
Adapalene—RARG—testis—hematologic cancer	0.000428	0.0516	CbGeAlD
Adapalene—RARA—lung—hematologic cancer	0.000427	0.0514	CbGeAlD
Adapalene—RARA—testis—hematologic cancer	0.000403	0.0485	CbGeAlD
Adapalene—RARB—lymph node—hematologic cancer	0.00038	0.0458	CbGeAlD
Adapalene—RARG—lymph node—hematologic cancer	0.00031	0.0374	CbGeAlD
Adapalene—RARA—lymph node—hematologic cancer	0.000292	0.0351	CbGeAlD
Adapalene—Dermatitis—Clofarabine—hematologic cancer	3.44e-05	0.00068	CcSEcCtD
Adapalene—Dermatitis—Daunorubicin—hematologic cancer	3.44e-05	0.00068	CcSEcCtD
Adapalene—Rash—Pentostatin—hematologic cancer	3.43e-05	0.000677	CcSEcCtD
Adapalene—Rash—Anagrelide—hematologic cancer	3.43e-05	0.000677	CcSEcCtD
Adapalene—Dermatitis—Anagrelide—hematologic cancer	3.42e-05	0.000677	CcSEcCtD
Adapalene—Dermatitis—Pentostatin—hematologic cancer	3.42e-05	0.000677	CcSEcCtD
Adapalene—Dry skin—Betamethasone—hematologic cancer	3.4e-05	0.000673	CcSEcCtD
Adapalene—Dry skin—Dexamethasone—hematologic cancer	3.4e-05	0.000673	CcSEcCtD
Adapalene—Hypersensitivity—Procarbazine—hematologic cancer	3.38e-05	0.000667	CcSEcCtD
Adapalene—Urticaria—Chlorambucil—hematologic cancer	3.37e-05	0.000667	CcSEcCtD
Adapalene—Angioedema—Thalidomide—hematologic cancer	3.34e-05	0.000661	CcSEcCtD
Adapalene—Pruritus—Busulfan—hematologic cancer	3.34e-05	0.000661	CcSEcCtD
Adapalene—Conjunctivitis—Prednisolone—hematologic cancer	3.33e-05	0.000659	CcSEcCtD
Adapalene—Pain—Vinblastine—hematologic cancer	3.33e-05	0.000657	CcSEcCtD
Adapalene—Skin exfoliation—Epirubicin—hematologic cancer	3.33e-05	0.000657	CcSEcCtD
Adapalene—Hypersensitivity—Dasatinib—hematologic cancer	3.31e-05	0.000654	CcSEcCtD
Adapalene—Hypersensitivity—Bexarotene—hematologic cancer	3.31e-05	0.000654	CcSEcCtD
Adapalene—Rash—Idarubicin—hematologic cancer	3.31e-05	0.000653	CcSEcCtD
Adapalene—Dermatitis—Idarubicin—hematologic cancer	3.3e-05	0.000653	CcSEcCtD
Adapalene—Hypersensitivity—Fludarabine—hematologic cancer	3.3e-05	0.000652	CcSEcCtD
Adapalene—Urticaria—Nilotinib—hematologic cancer	3.3e-05	0.000652	CcSEcCtD
Adapalene—Urticaria—Imatinib—hematologic cancer	3.28e-05	0.000648	CcSEcCtD
Adapalene—Convulsion—Thiotepa—hematologic cancer	3.28e-05	0.000648	CcSEcCtD
Adapalene—Erythema—Mitoxantrone—hematologic cancer	3.27e-05	0.000646	CcSEcCtD
Adapalene—Pruritus—Procarbazine—hematologic cancer	3.24e-05	0.000641	CcSEcCtD
Adapalene—Urticaria—Cladribine—hematologic cancer	3.22e-05	0.000637	CcSEcCtD
Adapalene—Rash—Teniposide—hematologic cancer	3.22e-05	0.000635	CcSEcCtD
Adapalene—Dermatitis—Teniposide—hematologic cancer	3.21e-05	0.000635	CcSEcCtD
Adapalene—Dermatitis contact—Doxorubicin—hematologic cancer	3.19e-05	0.00063	CcSEcCtD
Adapalene—Erythema—Gemcitabine—hematologic cancer	3.18e-05	0.000629	CcSEcCtD
Adapalene—Pruritus—Bexarotene—hematologic cancer	3.18e-05	0.000628	CcSEcCtD
Adapalene—Pruritus—Dasatinib—hematologic cancer	3.18e-05	0.000628	CcSEcCtD
Adapalene—Pruritus—Fludarabine—hematologic cancer	3.17e-05	0.000627	CcSEcCtD
Adapalene—Convulsion—Thalidomide—hematologic cancer	3.17e-05	0.000627	CcSEcCtD
Adapalene—Pain—Melphalan—hematologic cancer	3.16e-05	0.000625	CcSEcCtD
Adapalene—Angioedema—Ifosfamide—hematologic cancer	3.14e-05	0.000621	CcSEcCtD
Adapalene—Hypersensitivity—Chlorambucil—hematologic cancer	3.13e-05	0.000618	CcSEcCtD
Adapalene—Face oedema—Prednisone—hematologic cancer	3.12e-05	0.000617	CcSEcCtD
Adapalene—Skin exfoliation—Doxorubicin—hematologic cancer	3.08e-05	0.000608	CcSEcCtD
Adapalene—Pain—Lenalidomide—hematologic cancer	3.08e-05	0.000608	CcSEcCtD
Adapalene—Conjunctivitis—Triamcinolone—hematologic cancer	3.07e-05	0.000606	CcSEcCtD
Adapalene—Hypersensitivity—Nilotinib—hematologic cancer	3.06e-05	0.000605	CcSEcCtD
Adapalene—Convulsion—Carmustine—hematologic cancer	3.05e-05	0.000602	CcSEcCtD
Adapalene—Hypersensitivity—Imatinib—hematologic cancer	3.04e-05	0.000601	CcSEcCtD
Adapalene—Pain—Hydroxyurea—hematologic cancer	3.03e-05	0.0006	CcSEcCtD
Adapalene—Convulsion—Alitretinoin—hematologic cancer	3.02e-05	0.000596	CcSEcCtD
Adapalene—Pruritus—Chlorambucil—hematologic cancer	3e-05	0.000594	CcSEcCtD
Adapalene—Hypersensitivity—Cladribine—hematologic cancer	2.99e-05	0.000591	CcSEcCtD
Adapalene—Convulsion—Ifosfamide—hematologic cancer	2.98e-05	0.000589	CcSEcCtD
Adapalene—Rash—Busulfan—hematologic cancer	2.98e-05	0.000589	CcSEcCtD
Adapalene—Dermatitis—Busulfan—hematologic cancer	2.98e-05	0.000588	CcSEcCtD
Adapalene—Erythema—Cisplatin—hematologic cancer	2.97e-05	0.000586	CcSEcCtD
Adapalene—Dry skin—Prednisone—hematologic cancer	2.96e-05	0.000586	CcSEcCtD
Adapalene—Urticaria—Melphalan—hematologic cancer	2.94e-05	0.000581	CcSEcCtD
Adapalene—Pruritus—Nilotinib—hematologic cancer	2.94e-05	0.000581	CcSEcCtD
Adapalene—Pruritus—Imatinib—hematologic cancer	2.92e-05	0.000577	CcSEcCtD
Adapalene—Convulsion—Vincristine—hematologic cancer	2.91e-05	0.000574	CcSEcCtD
Adapalene—Rash—Procarbazine—hematologic cancer	2.89e-05	0.000571	CcSEcCtD
Adapalene—Dermatitis—Procarbazine—hematologic cancer	2.89e-05	0.000571	CcSEcCtD
Adapalene—Pruritus—Cladribine—hematologic cancer	2.87e-05	0.000567	CcSEcCtD
Adapalene—Hypersensitivity—Vinblastine—hematologic cancer	2.87e-05	0.000566	CcSEcCtD
Adapalene—Dermatitis exfoliative—Methotrexate—hematologic cancer	2.86e-05	0.000566	CcSEcCtD
Adapalene—Urticaria—Lenalidomide—hematologic cancer	2.86e-05	0.000565	CcSEcCtD
Adapalene—Rash—Bexarotene—hematologic cancer	2.83e-05	0.00056	CcSEcCtD
Adapalene—Rash—Dasatinib—hematologic cancer	2.83e-05	0.00056	CcSEcCtD
Adapalene—Pain—Bortezomib—hematologic cancer	2.83e-05	0.00056	CcSEcCtD
Adapalene—Dermatitis—Dasatinib—hematologic cancer	2.83e-05	0.000559	CcSEcCtD
Adapalene—Dermatitis—Bexarotene—hematologic cancer	2.83e-05	0.000559	CcSEcCtD
Adapalene—Convulsion—Mitoxantrone—hematologic cancer	2.83e-05	0.000559	CcSEcCtD
Adapalene—Rash—Fludarabine—hematologic cancer	2.83e-05	0.000558	CcSEcCtD
Adapalene—Dermatitis—Fludarabine—hematologic cancer	2.82e-05	0.000558	CcSEcCtD
Adapalene—Eczema—Epirubicin—hematologic cancer	2.81e-05	0.000556	CcSEcCtD
Adapalene—Pain—Bleomycin—hematologic cancer	2.81e-05	0.000555	CcSEcCtD
Adapalene—Eye pain—Epirubicin—hematologic cancer	2.8e-05	0.000554	CcSEcCtD
Adapalene—Conjunctivitis—Dexamethasone—hematologic cancer	2.78e-05	0.00055	CcSEcCtD
Adapalene—Conjunctivitis—Betamethasone—hematologic cancer	2.78e-05	0.00055	CcSEcCtD
Adapalene—Pain—Vinorelbine—hematologic cancer	2.76e-05	0.000546	CcSEcCtD
Adapalene—Hypersensitivity—Melphalan—hematologic cancer	2.73e-05	0.000539	CcSEcCtD
Adapalene—Dermatitis exfoliative—Epirubicin—hematologic cancer	2.68e-05	0.00053	CcSEcCtD
Adapalene—Erythema—Prednisolone—hematologic cancer	2.68e-05	0.00053	CcSEcCtD
Adapalene—Hypersensitivity—Lenalidomide—hematologic cancer	2.65e-05	0.000524	CcSEcCtD
Adapalene—Dermatitis bullous—Epirubicin—hematologic cancer	2.65e-05	0.000523	CcSEcCtD
Adapalene—Pain—Thiotepa—hematologic cancer	2.64e-05	0.000522	CcSEcCtD
Adapalene—Urticaria—Bortezomib—hematologic cancer	2.63e-05	0.00052	CcSEcCtD
Adapalene—Pruritus—Melphalan—hematologic cancer	2.62e-05	0.000517	CcSEcCtD
Adapalene—Rash—Nilotinib—hematologic cancer	2.62e-05	0.000517	CcSEcCtD
Adapalene—Dermatitis—Nilotinib—hematologic cancer	2.62e-05	0.000517	CcSEcCtD
Adapalene—Hypersensitivity—Hydroxyurea—hematologic cancer	2.61e-05	0.000517	CcSEcCtD
Adapalene—Urticaria—Bleomycin—hematologic cancer	2.61e-05	0.000516	CcSEcCtD
Adapalene—Eczema—Doxorubicin—hematologic cancer	2.6e-05	0.000515	CcSEcCtD
Adapalene—Rash—Imatinib—hematologic cancer	2.6e-05	0.000514	CcSEcCtD
Adapalene—Dermatitis—Imatinib—hematologic cancer	2.6e-05	0.000514	CcSEcCtD
Adapalene—Eye pain—Doxorubicin—hematologic cancer	2.59e-05	0.000512	CcSEcCtD
Adapalene—Convulsion—Cisplatin—hematologic cancer	2.57e-05	0.000508	CcSEcCtD
Adapalene—Urticaria—Vinorelbine—hematologic cancer	2.57e-05	0.000508	CcSEcCtD
Adapalene—Rash—Cladribine—hematologic cancer	2.56e-05	0.000505	CcSEcCtD
Adapalene—Dermatitis—Cladribine—hematologic cancer	2.56e-05	0.000505	CcSEcCtD
Adapalene—Pain—Thalidomide—hematologic cancer	2.55e-05	0.000505	CcSEcCtD
Adapalene—Pruritus—Lenalidomide—hematologic cancer	2.55e-05	0.000503	CcSEcCtD
Adapalene—Dermatitis exfoliative—Doxorubicin—hematologic cancer	2.48e-05	0.00049	CcSEcCtD
Adapalene—Erythema—Triamcinolone—hematologic cancer	2.47e-05	0.000487	CcSEcCtD
Adapalene—Urticaria—Thiotepa—hematologic cancer	2.45e-05	0.000485	CcSEcCtD
Adapalene—Pain—Carmustine—hematologic cancer	2.45e-05	0.000485	CcSEcCtD
Adapalene—Angioedema—Prednisolone—hematologic cancer	2.45e-05	0.000484	CcSEcCtD
Adapalene—Dermatitis bullous—Doxorubicin—hematologic cancer	2.45e-05	0.000484	CcSEcCtD
Adapalene—Face oedema—Epirubicin—hematologic cancer	2.44e-05	0.000483	CcSEcCtD
Adapalene—Hypersensitivity—Bortezomib—hematologic cancer	2.44e-05	0.000482	CcSEcCtD
Adapalene—Pain—Alitretinoin—hematologic cancer	2.43e-05	0.00048	CcSEcCtD
Adapalene—Hypersensitivity—Bleomycin—hematologic cancer	2.42e-05	0.000478	CcSEcCtD
Adapalene—Pain—Ifosfamide—hematologic cancer	2.4e-05	0.000475	CcSEcCtD
Adapalene—Hypersensitivity—Vinorelbine—hematologic cancer	2.38e-05	0.000471	CcSEcCtD
Adapalene—Urticaria—Thalidomide—hematologic cancer	2.37e-05	0.000469	CcSEcCtD
Adapalene—Convulsion—Etoposide—hematologic cancer	2.35e-05	0.000465	CcSEcCtD
Adapalene—Pruritus—Bortezomib—hematologic cancer	2.34e-05	0.000463	CcSEcCtD
Adapalene—Pain—Vincristine—hematologic cancer	2.34e-05	0.000463	CcSEcCtD
Adapalene—Rash—Melphalan—hematologic cancer	2.33e-05	0.000461	CcSEcCtD
Adapalene—Dermatitis—Melphalan—hematologic cancer	2.33e-05	0.000461	CcSEcCtD
Adapalene—Pruritus—Bleomycin—hematologic cancer	2.32e-05	0.000459	CcSEcCtD
Adapalene—Convulsion—Prednisolone—hematologic cancer	2.32e-05	0.000459	CcSEcCtD
Adapalene—Dry skin—Epirubicin—hematologic cancer	2.32e-05	0.000458	CcSEcCtD
Adapalene—Pruritus—Vinorelbine—hematologic cancer	2.29e-05	0.000452	CcSEcCtD
Adapalene—Pain—Irinotecan—hematologic cancer	2.28e-05	0.000451	CcSEcCtD
Adapalene—Pain—Mitoxantrone—hematologic cancer	2.28e-05	0.000451	CcSEcCtD
Adapalene—Hypersensitivity—Thiotepa—hematologic cancer	2.28e-05	0.00045	CcSEcCtD
Adapalene—Rash—Lenalidomide—hematologic cancer	2.27e-05	0.000448	CcSEcCtD
Adapalene—Dermatitis—Lenalidomide—hematologic cancer	2.27e-05	0.000448	CcSEcCtD
Adapalene—Face oedema—Doxorubicin—hematologic cancer	2.26e-05	0.000447	CcSEcCtD
Adapalene—Urticaria—Alitretinoin—hematologic cancer	2.26e-05	0.000446	CcSEcCtD
Adapalene—Angioedema—Triamcinolone—hematologic cancer	2.25e-05	0.000445	CcSEcCtD
Adapalene—Rash—Hydroxyurea—hematologic cancer	2.24e-05	0.000442	CcSEcCtD
Adapalene—Erythema—Betamethasone—hematologic cancer	2.24e-05	0.000442	CcSEcCtD
Adapalene—Erythema—Dexamethasone—hematologic cancer	2.24e-05	0.000442	CcSEcCtD
Adapalene—Dermatitis—Hydroxyurea—hematologic cancer	2.24e-05	0.000442	CcSEcCtD
Adapalene—Urticaria—Ifosfamide—hematologic cancer	2.23e-05	0.000441	CcSEcCtD
Adapalene—Pain—Gemcitabine—hematologic cancer	2.22e-05	0.000439	CcSEcCtD
Adapalene—Hypersensitivity—Thalidomide—hematologic cancer	2.2e-05	0.000435	CcSEcCtD
Adapalene—Pruritus—Thiotepa—hematologic cancer	2.18e-05	0.000432	CcSEcCtD
Adapalene—Dry skin—Doxorubicin—hematologic cancer	2.15e-05	0.000424	CcSEcCtD
Adapalene—Convulsion—Triamcinolone—hematologic cancer	2.14e-05	0.000422	CcSEcCtD
Adapalene—Photosensitivity reaction—Methotrexate—hematologic cancer	2.13e-05	0.000421	CcSEcCtD
Adapalene—Urticaria—Mitoxantrone—hematologic cancer	2.12e-05	0.000419	CcSEcCtD
Adapalene—Hypersensitivity—Carmustine—hematologic cancer	2.11e-05	0.000418	CcSEcCtD
Adapalene—Pruritus—Thalidomide—hematologic cancer	2.11e-05	0.000418	CcSEcCtD
Adapalene—Hypersensitivity—Alitretinoin—hematologic cancer	2.09e-05	0.000414	CcSEcCtD
Adapalene—Rash—Bortezomib—hematologic cancer	2.09e-05	0.000413	CcSEcCtD
Adapalene—Dermatitis—Bortezomib—hematologic cancer	2.09e-05	0.000412	CcSEcCtD
Adapalene—Rash—Bleomycin—hematologic cancer	2.07e-05	0.000409	CcSEcCtD
Adapalene—Pain—Cisplatin—hematologic cancer	2.07e-05	0.000409	CcSEcCtD
Adapalene—Dermatitis—Bleomycin—hematologic cancer	2.07e-05	0.000409	CcSEcCtD
Adapalene—Hypersensitivity—Ifosfamide—hematologic cancer	2.07e-05	0.000409	CcSEcCtD
Adapalene—Angioedema—Dexamethasone—hematologic cancer	2.04e-05	0.000404	CcSEcCtD
Adapalene—Angioedema—Betamethasone—hematologic cancer	2.04e-05	0.000404	CcSEcCtD
Adapalene—Rash—Vinorelbine—hematologic cancer	2.04e-05	0.000403	CcSEcCtD
Adapalene—Dermatitis—Vinorelbine—hematologic cancer	2.04e-05	0.000402	CcSEcCtD
Adapalene—Conjunctivitis—Methotrexate—hematologic cancer	2.02e-05	0.0004	CcSEcCtD
Adapalene—Hypersensitivity—Vincristine—hematologic cancer	2.02e-05	0.000399	CcSEcCtD
Adapalene—Pruritus—Alitretinoin—hematologic cancer	2.01e-05	0.000397	CcSEcCtD
Adapalene—Photosensitivity reaction—Epirubicin—hematologic cancer	2e-05	0.000394	CcSEcCtD
Adapalene—Pruritus—Ifosfamide—hematologic cancer	1.99e-05	0.000393	CcSEcCtD
Adapalene—Hypersensitivity—Irinotecan—hematologic cancer	1.96e-05	0.000388	CcSEcCtD
Adapalene—Hypersensitivity—Mitoxantrone—hematologic cancer	1.96e-05	0.000388	CcSEcCtD
Adapalene—Erythema—Prednisone—hematologic cancer	1.95e-05	0.000385	CcSEcCtD
Adapalene—Rash—Thiotepa—hematologic cancer	1.95e-05	0.000385	CcSEcCtD
Adapalene—Dermatitis—Thiotepa—hematologic cancer	1.95e-05	0.000384	CcSEcCtD
Adapalene—Convulsion—Betamethasone—hematologic cancer	1.94e-05	0.000383	CcSEcCtD
Adapalene—Convulsion—Dexamethasone—hematologic cancer	1.94e-05	0.000383	CcSEcCtD
Adapalene—Pain—Etoposide—hematologic cancer	1.9e-05	0.000375	CcSEcCtD
Adapalene—Conjunctivitis—Epirubicin—hematologic cancer	1.89e-05	0.000374	CcSEcCtD
Adapalene—Rash—Thalidomide—hematologic cancer	1.88e-05	0.000372	CcSEcCtD
Adapalene—Dermatitis—Thalidomide—hematologic cancer	1.88e-05	0.000372	CcSEcCtD
Adapalene—Pain—Prednisolone—hematologic cancer	1.87e-05	0.00037	CcSEcCtD
Adapalene—Hepatitis—Methotrexate—hematologic cancer	1.87e-05	0.00037	CcSEcCtD
Adapalene—Photosensitivity reaction—Doxorubicin—hematologic cancer	1.85e-05	0.000365	CcSEcCtD
Adapalene—Pruritus—Gemcitabine—hematologic cancer	1.84e-05	0.000363	CcSEcCtD
Adapalene—Rash—Carmustine—hematologic cancer	1.81e-05	0.000357	CcSEcCtD
Adapalene—Dermatitis—Carmustine—hematologic cancer	1.81e-05	0.000357	CcSEcCtD
Adapalene—Rash—Alitretinoin—hematologic cancer	1.79e-05	0.000354	CcSEcCtD
Adapalene—Dermatitis—Alitretinoin—hematologic cancer	1.79e-05	0.000354	CcSEcCtD
Adapalene—Hypersensitivity—Cisplatin—hematologic cancer	1.78e-05	0.000352	CcSEcCtD
Adapalene—Angioedema—Prednisone—hematologic cancer	1.78e-05	0.000352	CcSEcCtD
Adapalene—Rash—Ifosfamide—hematologic cancer	1.77e-05	0.00035	CcSEcCtD
Adapalene—Dermatitis—Ifosfamide—hematologic cancer	1.77e-05	0.00035	CcSEcCtD
Adapalene—Urticaria—Etoposide—hematologic cancer	1.76e-05	0.000348	CcSEcCtD
Adapalene—Conjunctivitis—Doxorubicin—hematologic cancer	1.75e-05	0.000346	CcSEcCtD
Adapalene—Hepatitis—Epirubicin—hematologic cancer	1.75e-05	0.000346	CcSEcCtD
Adapalene—Urticaria—Prednisolone—hematologic cancer	1.74e-05	0.000343	CcSEcCtD
Adapalene—Rash—Vincristine—hematologic cancer	1.73e-05	0.000341	CcSEcCtD
Adapalene—Dermatitis—Vincristine—hematologic cancer	1.72e-05	0.000341	CcSEcCtD
Adapalene—Pain—Triamcinolone—hematologic cancer	1.72e-05	0.00034	CcSEcCtD
Adapalene—Convulsion—Prednisone—hematologic cancer	1.69e-05	0.000333	CcSEcCtD
Adapalene—Rash—Mitoxantrone—hematologic cancer	1.68e-05	0.000332	CcSEcCtD
Adapalene—Rash—Irinotecan—hematologic cancer	1.68e-05	0.000332	CcSEcCtD
Adapalene—Dermatitis—Irinotecan—hematologic cancer	1.68e-05	0.000332	CcSEcCtD
Adapalene—Dermatitis—Mitoxantrone—hematologic cancer	1.68e-05	0.000332	CcSEcCtD
Adapalene—Rash—Gemcitabine—hematologic cancer	1.64e-05	0.000324	CcSEcCtD
Adapalene—Dermatitis—Gemcitabine—hematologic cancer	1.64e-05	0.000323	CcSEcCtD
Adapalene—Hypersensitivity—Etoposide—hematologic cancer	1.63e-05	0.000323	CcSEcCtD
Adapalene—Erythema—Methotrexate—hematologic cancer	1.63e-05	0.000322	CcSEcCtD
Adapalene—Hepatitis—Doxorubicin—hematologic cancer	1.62e-05	0.00032	CcSEcCtD
Adapalene—Hypersensitivity—Prednisolone—hematologic cancer	1.61e-05	0.000319	CcSEcCtD
Adapalene—Urticaria—Triamcinolone—hematologic cancer	1.6e-05	0.000316	CcSEcCtD
Adapalene—Pruritus—Etoposide—hematologic cancer	1.57e-05	0.00031	CcSEcCtD
Adapalene—Pain—Betamethasone—hematologic cancer	1.56e-05	0.000308	CcSEcCtD
Adapalene—Pain—Dexamethasone—hematologic cancer	1.56e-05	0.000308	CcSEcCtD
Adapalene—Rash—Cisplatin—hematologic cancer	1.53e-05	0.000302	CcSEcCtD
Adapalene—Dermatitis—Cisplatin—hematologic cancer	1.53e-05	0.000301	CcSEcCtD
Adapalene—Erythema—Epirubicin—hematologic cancer	1.52e-05	0.000301	CcSEcCtD
Adapalene—Hypersensitivity—Triamcinolone—hematologic cancer	1.48e-05	0.000293	CcSEcCtD
Adapalene—Urticaria—Dexamethasone—hematologic cancer	1.45e-05	0.000287	CcSEcCtD
Adapalene—Urticaria—Betamethasone—hematologic cancer	1.45e-05	0.000287	CcSEcCtD
Adapalene—Pruritus—Triamcinolone—hematologic cancer	1.42e-05	0.000281	CcSEcCtD
Adapalene—Convulsion—Methotrexate—hematologic cancer	1.41e-05	0.000279	CcSEcCtD
Adapalene—Erythema—Doxorubicin—hematologic cancer	1.41e-05	0.000279	CcSEcCtD
Adapalene—Rash—Etoposide—hematologic cancer	1.4e-05	0.000276	CcSEcCtD
Adapalene—Dermatitis—Etoposide—hematologic cancer	1.4e-05	0.000276	CcSEcCtD
Adapalene—Rash—Prednisolone—hematologic cancer	1.38e-05	0.000273	CcSEcCtD
Adapalene—Dermatitis—Prednisolone—hematologic cancer	1.38e-05	0.000272	CcSEcCtD
Adapalene—Convulsion—Epirubicin—hematologic cancer	1.32e-05	0.000261	CcSEcCtD
Adapalene—Pruritus—Dexamethasone—hematologic cancer	1.29e-05	0.000255	CcSEcCtD
Adapalene—Pruritus—Betamethasone—hematologic cancer	1.29e-05	0.000255	CcSEcCtD
Adapalene—Rash—Triamcinolone—hematologic cancer	1.27e-05	0.000251	CcSEcCtD
Adapalene—Dermatitis—Triamcinolone—hematologic cancer	1.27e-05	0.00025	CcSEcCtD
Adapalene—Urticaria—Prednisone—hematologic cancer	1.26e-05	0.00025	CcSEcCtD
Adapalene—Convulsion—Doxorubicin—hematologic cancer	1.22e-05	0.000241	CcSEcCtD
Adapalene—Hypersensitivity—Prednisone—hematologic cancer	1.17e-05	0.000231	CcSEcCtD
Adapalene—Rash—Dexamethasone—hematologic cancer	1.15e-05	0.000227	CcSEcCtD
Adapalene—Rash—Betamethasone—hematologic cancer	1.15e-05	0.000227	CcSEcCtD
Adapalene—Dermatitis—Dexamethasone—hematologic cancer	1.15e-05	0.000227	CcSEcCtD
Adapalene—Dermatitis—Betamethasone—hematologic cancer	1.15e-05	0.000227	CcSEcCtD
Adapalene—Pain—Methotrexate—hematologic cancer	1.14e-05	0.000225	CcSEcCtD
Adapalene—Pruritus—Prednisone—hematologic cancer	1.12e-05	0.000222	CcSEcCtD
Adapalene—Pain—Epirubicin—hematologic cancer	1.06e-05	0.00021	CcSEcCtD
Adapalene—Urticaria—Methotrexate—hematologic cancer	1.06e-05	0.000209	CcSEcCtD
Adapalene—Rash—Prednisone—hematologic cancer	1e-05	0.000198	CcSEcCtD
Adapalene—Dermatitis—Prednisone—hematologic cancer	1e-05	0.000198	CcSEcCtD
Adapalene—Urticaria—Epirubicin—hematologic cancer	9.88e-06	0.000195	CcSEcCtD
Adapalene—Pain—Doxorubicin—hematologic cancer	9.84e-06	0.000194	CcSEcCtD
Adapalene—Hypersensitivity—Methotrexate—hematologic cancer	9.79e-06	0.000193	CcSEcCtD
Adapalene—Pruritus—Methotrexate—hematologic cancer	9.4e-06	0.000186	CcSEcCtD
Adapalene—Hypersensitivity—Epirubicin—hematologic cancer	9.16e-06	0.000181	CcSEcCtD
Adapalene—Urticaria—Doxorubicin—hematologic cancer	9.14e-06	0.000181	CcSEcCtD
Adapalene—Pruritus—Epirubicin—hematologic cancer	8.8e-06	0.000174	CcSEcCtD
Adapalene—Hypersensitivity—Doxorubicin—hematologic cancer	8.48e-06	0.000167	CcSEcCtD
Adapalene—Rash—Methotrexate—hematologic cancer	8.38e-06	0.000166	CcSEcCtD
Adapalene—Dermatitis—Methotrexate—hematologic cancer	8.37e-06	0.000165	CcSEcCtD
Adapalene—RXRG—Gene Expression—EZH2—hematologic cancer	8.31e-06	0.000209	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—PARP1—hematologic cancer	8.28e-06	0.000209	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ADCY7—hematologic cancer	8.21e-06	0.000207	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	8.18e-06	0.000206	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—CDKN1A—hematologic cancer	8.17e-06	0.000206	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—NUP214—hematologic cancer	8.15e-06	0.000205	CbGpPWpGaD
Adapalene—RARB—Gene Expression—EZH2—hematologic cancer	8.15e-06	0.000205	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—H3F3A—hematologic cancer	8.15e-06	0.000205	CbGpPWpGaD
Adapalene—RARA—Gene Expression—H3F3A—hematologic cancer	8.15e-06	0.000205	CbGpPWpGaD
Adapalene—Pruritus—Doxorubicin—hematologic cancer	8.14e-06	0.000161	CcSEcCtD
Adapalene—RXRG—Gene Expression—PARP1—hematologic cancer	8.13e-06	0.000205	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	8.11e-06	0.000204	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	8.01e-06	0.000202	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PTPRC—hematologic cancer	8e-06	0.000201	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—CREBBP—hematologic cancer	8e-06	0.000201	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—CREBBP—hematologic cancer	8e-06	0.000201	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ABCG2—hematologic cancer	7.99e-06	0.000201	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PARP1—hematologic cancer	7.98e-06	0.000201	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—HDAC2—hematologic cancer	7.85e-06	0.000198	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.85e-06	0.000198	CbGpPWpGaD
Adapalene—Rash—Epirubicin—hematologic cancer	7.84e-06	0.000155	CcSEcCtD
Adapalene—Dermatitis—Epirubicin—hematologic cancer	7.83e-06	0.000155	CcSEcCtD
Adapalene—RARA—Gene Expression—EZH2—hematologic cancer	7.81e-06	0.000197	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—EZH2—hematologic cancer	7.81e-06	0.000197	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	7.81e-06	0.000197	CbGpPWpGaD
Adapalene—RARB—Gene Expression—HDAC2—hematologic cancer	7.7e-06	0.000194	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CDA—hematologic cancer	7.66e-06	0.000193	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PARP1—hematologic cancer	7.65e-06	0.000193	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PARP1—hematologic cancer	7.65e-06	0.000193	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	7.62e-06	0.000192	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—RARA—hematologic cancer	7.46e-06	0.000188	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—TET2—hematologic cancer	7.46e-06	0.000188	CbGpPWpGaD
Adapalene—RARG—Gene Expression—AR—hematologic cancer	7.44e-06	0.000187	CbGpPWpGaD
Adapalene—RARA—Gene Expression—HDAC2—hematologic cancer	7.38e-06	0.000186	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—HDAC2—hematologic cancer	7.38e-06	0.000186	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PC—hematologic cancer	7.37e-06	0.000186	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—RPLP1—hematologic cancer	7.32e-06	0.000184	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—STAT3—hematologic cancer	7.29e-06	0.000184	CbGpPWpGaD
Adapalene—Rash—Doxorubicin—hematologic cancer	7.25e-06	0.000143	CcSEcCtD
Adapalene—Dermatitis—Doxorubicin—hematologic cancer	7.25e-06	0.000143	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	7.23e-06	0.000182	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	7.13e-06	0.00018	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC35B2—hematologic cancer	7.12e-06	0.000179	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GBA—hematologic cancer	7.12e-06	0.000179	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—TFRC—hematologic cancer	7.12e-06	0.000179	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HSP90AA1—hematologic cancer	6.99e-06	0.000176	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NR0B2—hematologic cancer	6.94e-06	0.000175	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—AR—hematologic cancer	6.92e-06	0.000174	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.91e-06	0.000174	CbGpPWpGaD
Adapalene—RARG—Gene Expression—CDKN2B—hematologic cancer	6.86e-06	0.000173	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—AR—hematologic cancer	6.8e-06	0.000171	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TGFB1—hematologic cancer	6.76e-06	0.00017	CbGpPWpGaD
Adapalene—RARB—Gene Expression—AR—hematologic cancer	6.67e-06	0.000168	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.62e-06	0.000167	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—DNMT3A—hematologic cancer	6.62e-06	0.000167	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ELL—hematologic cancer	6.52e-06	0.000164	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTAP—hematologic cancer	6.51e-06	0.000164	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	6.51e-06	0.000164	CbGpPWpGaD
Adapalene—RARG—Gene Expression—NCOR1—hematologic cancer	6.5e-06	0.000164	CbGpPWpGaD
Adapalene—RARA—Gene Expression—AR—hematologic cancer	6.4e-06	0.000161	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—AR—hematologic cancer	6.4e-06	0.000161	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—CDKN2B—hematologic cancer	6.38e-06	0.000161	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	6.38e-06	0.000161	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TNF—hematologic cancer	6.31e-06	0.000159	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—GRB2—hematologic cancer	6.3e-06	0.000159	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—CDKN2B—hematologic cancer	6.27e-06	0.000158	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NCOR2—hematologic cancer	6.26e-06	0.000158	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	6.21e-06	0.000156	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	6.19e-06	0.000156	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—TGFB1—hematologic cancer	6.16e-06	0.000155	CbGpPWpGaD
Adapalene—RARB—Gene Expression—CDKN2B—hematologic cancer	6.15e-06	0.000155	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—ABL1—hematologic cancer	6.06e-06	0.000153	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—NCOR1—hematologic cancer	6.05e-06	0.000153	CbGpPWpGaD
Adapalene—RARG—Gene Expression—NR3C1—hematologic cancer	6.02e-06	0.000152	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	6e-06	0.000151	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	5.99e-06	0.000151	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	5.99e-06	0.000151	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.97e-06	0.000151	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—NCOR1—hematologic cancer	5.95e-06	0.00015	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CDKN2B—hematologic cancer	5.9e-06	0.000149	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CDKN2B—hematologic cancer	5.9e-06	0.000149	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	5.86e-06	0.000148	CbGpPWpGaD
Adapalene—RARB—Gene Expression—NCOR1—hematologic cancer	5.83e-06	0.000147	CbGpPWpGaD
Adapalene—RXRA—Metabolism—FHL2—hematologic cancer	5.8e-06	0.000146	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—AGO2—hematologic cancer	5.77e-06	0.000146	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HES1—hematologic cancer	5.73e-06	0.000144	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	5.71e-06	0.000144	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NCOR1—hematologic cancer	5.7e-06	0.000144	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AGRN—hematologic cancer	5.69e-06	0.000143	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—DNMT3B—hematologic cancer	5.66e-06	0.000143	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—H3F3B—hematologic cancer	5.66e-06	0.000143	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—NR3C1—hematologic cancer	5.6e-06	0.000141	CbGpPWpGaD
Adapalene—RARA—Gene Expression—NCOR1—hematologic cancer	5.59e-06	0.000141	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—NCOR1—hematologic cancer	5.59e-06	0.000141	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	5.56e-06	0.00014	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—FOXO1—hematologic cancer	5.55e-06	0.00014	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—MYC—hematologic cancer	5.52e-06	0.000139	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—NR3C1—hematologic cancer	5.5e-06	0.000139	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—JAK1—hematologic cancer	5.44e-06	0.000137	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	5.41e-06	0.000136	CbGpPWpGaD
Adapalene—RARB—Gene Expression—NR3C1—hematologic cancer	5.4e-06	0.000136	CbGpPWpGaD
Adapalene—RXRA—Metabolism—IDH2—hematologic cancer	5.4e-06	0.000136	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HMMR—hematologic cancer	5.4e-06	0.000136	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MAPK14—hematologic cancer	5.21e-06	0.000131	CbGpPWpGaD
Adapalene—RARA—Gene Expression—NR3C1—hematologic cancer	5.17e-06	0.00013	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—NR3C1—hematologic cancer	5.17e-06	0.00013	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—RPS14—hematologic cancer	5.17e-06	0.00013	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	5.12e-06	0.000129	CbGpPWpGaD
Adapalene—RARG—Gene Expression—ESR1—hematologic cancer	5.11e-06	0.000129	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NUP98—hematologic cancer	5.09e-06	0.000128	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IL6—hematologic cancer	5.09e-06	0.000128	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.09e-06	0.000128	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ARNTL—hematologic cancer	5.07e-06	0.000128	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—MYC—hematologic cancer	5.05e-06	0.000127	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.98e-06	0.000126	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	4.98e-06	0.000125	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	4.97e-06	0.000125	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—MYC—hematologic cancer	4.95e-06	0.000125	CbGpPWpGaD
Adapalene—RARG—Gene Expression—NOTCH1—hematologic cancer	4.94e-06	0.000124	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CA9—hematologic cancer	4.94e-06	0.000124	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ACP5—hematologic cancer	4.94e-06	0.000124	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NUP214—hematologic cancer	4.91e-06	0.000124	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NCOR2—hematologic cancer	4.87e-06	0.000123	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MAPK14—hematologic cancer	4.76e-06	0.00012	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ESR1—hematologic cancer	4.75e-06	0.00012	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—MYC—hematologic cancer	4.75e-06	0.00012	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—MYC—hematologic cancer	4.75e-06	0.00012	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ESR1—hematologic cancer	4.67e-06	0.000118	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MAPK14—hematologic cancer	4.67e-06	0.000118	CbGpPWpGaD
Adapalene—RXRA—Metabolism—IDH1—hematologic cancer	4.64e-06	0.000117	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.64e-06	0.000117	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.6e-06	0.000116	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—NOTCH1—hematologic cancer	4.6e-06	0.000116	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TXN—hematologic cancer	4.59e-06	0.000116	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ABCC3—hematologic cancer	4.59e-06	0.000116	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTO1—hematologic cancer	4.59e-06	0.000116	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ESR1—hematologic cancer	4.58e-06	0.000115	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MAPK14—hematologic cancer	4.56e-06	0.000115	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EIF4EBP1—hematologic cancer	4.52e-06	0.000114	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HSPB1—hematologic cancer	4.52e-06	0.000114	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—NOTCH1—hematologic cancer	4.52e-06	0.000114	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MET—hematologic cancer	4.49e-06	0.000113	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CDK4—hematologic cancer	4.49e-06	0.000113	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SPHK1—hematologic cancer	4.49e-06	0.000113	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MAPK14—hematologic cancer	4.48e-06	0.000113	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MAPK14—hematologic cancer	4.48e-06	0.000113	CbGpPWpGaD
Adapalene—RARG—Gene Expression—CREBBP—hematologic cancer	4.48e-06	0.000113	CbGpPWpGaD
Adapalene—RARB—Gene Expression—NOTCH1—hematologic cancer	4.43e-06	0.000112	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ESR1—hematologic cancer	4.39e-06	0.000111	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—ESR1—hematologic cancer	4.39e-06	0.000111	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—SMC1A—hematologic cancer	4.33e-06	0.000109	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NOTCH1—hematologic cancer	4.33e-06	0.000109	CbGpPWpGaD
Adapalene—RXRA—Metabolism—UGT1A1—hematologic cancer	4.31e-06	0.000109	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—NOTCH1—hematologic cancer	4.25e-06	0.000107	CbGpPWpGaD
Adapalene—RARA—Gene Expression—NOTCH1—hematologic cancer	4.25e-06	0.000107	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—H3F3A—hematologic cancer	4.25e-06	0.000107	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.23e-06	0.000106	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CRABP1—hematologic cancer	4.2e-06	0.000106	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC22A1—hematologic cancer	4.2e-06	0.000106	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—CREBBP—hematologic cancer	4.17e-06	0.000105	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PTPN11—hematologic cancer	4.16e-06	0.000105	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—CREBBP—hematologic cancer	4.09e-06	0.000103	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ALOX5—hematologic cancer	4.09e-06	0.000103	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.09e-06	0.000103	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EZH2—hematologic cancer	4.07e-06	0.000103	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CREB1—hematologic cancer	4.03e-06	0.000101	CbGpPWpGaD
Adapalene—RARB—Gene Expression—CREBBP—hematologic cancer	4.02e-06	0.000101	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PARP1—hematologic cancer	3.99e-06	0.0001	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NUP98—hematologic cancer	3.96e-06	9.98e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6R—hematologic cancer	3.93e-06	9.9e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CREBBP—hematologic cancer	3.92e-06	9.88e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CREBBP—hematologic cancer	3.85e-06	9.7e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CREBBP—hematologic cancer	3.85e-06	9.7e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HDAC2—hematologic cancer	3.85e-06	9.69e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ADCY7—hematologic cancer	3.84e-06	9.69e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NCOA3—hematologic cancer	3.84e-06	9.69e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NUP214—hematologic cancer	3.82e-06	9.62e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.78e-06	9.52e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MAP2K1—hematologic cancer	3.74e-06	9.43e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTR—hematologic cancer	3.74e-06	9.42e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ABCG2—hematologic cancer	3.74e-06	9.42e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ENO2—hematologic cancer	3.67e-06	9.24e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—FGF2—hematologic cancer	3.56e-06	8.97e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTT1—hematologic cancer	3.56e-06	8.96e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.5e-06	8.83e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SDC1—hematologic cancer	3.48e-06	8.76e-05	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.45e-06	8.7e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—JAK2—hematologic cancer	3.41e-06	8.6e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—AR—hematologic cancer	3.33e-06	8.4e-05	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.33e-06	8.39e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.32e-06	8.37e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.28e-06	8.26e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.14e-06	7.9e-05	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ALB—hematologic cancer	3.12e-06	7.86e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CDKN2B—hematologic cancer	3.07e-06	7.74e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NQO1—hematologic cancer	2.96e-06	7.45e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CD44—hematologic cancer	2.96e-06	7.45e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NCOR1—hematologic cancer	2.91e-06	7.34e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.9e-06	7.29e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYCS—hematologic cancer	2.8e-06	7.05e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HSP90AA1—hematologic cancer	2.78e-06	7e-05	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MAPK3—hematologic cancer	2.73e-06	6.88e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NR3C1—hematologic cancer	2.7e-06	6.79e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EP300—hematologic cancer	2.67e-06	6.73e-05	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MYC—hematologic cancer	2.66e-06	6.69e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—SRC—hematologic cancer	2.6e-06	6.55e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—VEGFA—hematologic cancer	2.53e-06	6.38e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—STAT3—hematologic cancer	2.51e-06	6.31e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.5e-06	6.3e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NRAS—hematologic cancer	2.5e-06	6.3e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MAPK3—hematologic cancer	2.5e-06	6.3e-05	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—MYC—hematologic cancer	2.47e-06	6.23e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTP1—hematologic cancer	2.47e-06	6.21e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MAPK3—hematologic cancer	2.45e-06	6.17e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MYC—hematologic cancer	2.43e-06	6.12e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MAPK3—hematologic cancer	2.39e-06	6.03e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.39e-06	6.01e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MYC—hematologic cancer	2.38e-06	6e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MAPK3—hematologic cancer	2.35e-06	5.92e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MAPK3—hematologic cancer	2.35e-06	5.92e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ABCB1—hematologic cancer	2.33e-06	5.88e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MAPK14—hematologic cancer	2.33e-06	5.88e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TGFB1—hematologic cancer	2.32e-06	5.85e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—ESR1—hematologic cancer	2.29e-06	5.77e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MYC—hematologic cancer	2.28e-06	5.76e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MYC—hematologic cancer	2.28e-06	5.76e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTM1—hematologic cancer	2.27e-06	5.71e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—NCOR1—hematologic cancer	2.27e-06	5.71e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—NOTCH1—hematologic cancer	2.21e-06	5.58e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TNF—hematologic cancer	2.17e-06	5.46e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KRAS—hematologic cancer	2.15e-06	5.42e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CREBBP—hematologic cancer	2.01e-06	5.06e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—MTHFR—hematologic cancer	2e-06	5.05e-05	CbGpPWpGaD
Adapalene—RARG—Gene Expression—AKT1—hematologic cancer	1.84e-06	4.64e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HRAS—hematologic cancer	1.83e-06	4.61e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.76e-06	4.45e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6—hematologic cancer	1.75e-06	4.41e-05	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—AKT1—hematologic cancer	1.69e-06	4.25e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CG—hematologic cancer	1.68e-06	4.24e-05	CbGpPWpGaD
Adapalene—RARB—Gene Expression—AKT1—hematologic cancer	1.65e-06	4.16e-05	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—AKT1—hematologic cancer	1.61e-06	4.07e-05	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—AKT1—hematologic cancer	1.58e-06	3.99e-05	CbGpPWpGaD
Adapalene—RARA—Gene Expression—AKT1—hematologic cancer	1.58e-06	3.99e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CREBBP—hematologic cancer	1.56e-06	3.93e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CD—hematologic cancer	1.48e-06	3.73e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ALB—hematologic cancer	1.46e-06	3.68e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3R1—hematologic cancer	1.4e-06	3.52e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CB—hematologic cancer	1.29e-06	3.25e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MAPK3—hematologic cancer	1.22e-06	3.08e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MYC—hematologic cancer	1.19e-06	3e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTEN—hematologic cancer	1.11e-06	2.81e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—EP300—hematologic cancer	1.06e-06	2.68e-05	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—AKT1—hematologic cancer	8.26e-07	2.08e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CA—hematologic cancer	7.86e-07	1.98e-05	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AKT1—hematologic cancer	6.42e-07	1.62e-05	CbGpPWpGaD
